May 10, 2005, North Brunswick, NJ -- Provid Pharmaceuticals announces move to expanded laboratories in North Brunswick, NJ
Provid Pharmaceuticals Inc. has relocated to a new facility in North
Brunswick, NJ on the campus of the Technology Center of New Jersey, a project
developed by the New Jersey Economic Development Authority (NJEDA) on US
Route 1 near the Rutgers campus in New Brunswick. The laboratory was
designed by CUH2A Architects and built by Torcon, Inc. as part of the expansion
of the Rutgers Technology Center. The NJEDA partnered with the Rutgers
University Division of Research and Sponsored Programs to build the
facility. The location is within a newly designated New Jersey Innovation
Zone and adjacent to the NJEDA Commercialization Center.
Provid’s CEO, Dr. Gary Olson, commented, "the expanded laboratories and close
relationship with the NJEDA and Rutgers are important to Provid’s future
growth and ability to form collaborations and strategic alliances with the
biotech industry in New Jersey, and elsewhere." Provid’s relationship
with New Jersey and the NJEDA is a strong one, with Provid being the recipient
of an NJEDA Springboard Fund II award to pursue research in autoimmune diseases,
and of a postdoctoral fellowship program via the New Jersey Commission on
Science and Technology.
Provid is a chemistry-based drug discovery company with expertise in all
aspects of medicinal chemistry, structure-based drug design, lead optimization,
protein biochemistry and assay development. The company offers collaborative
discovery services to biotech companies and academic groups that need medicinal
chemistry expertise to transform their biologically driven research into
drug molecules. In addition, Provid pursues internal programs for the
discovery of novel therapeutics for autoimmune diseases based on a platform
technology in the field of peptide mimetics.
The new address is as follows:
Provid Pharmaceuticals Inc.
671 US Route 1
North Brunswick, NJ 08902
(732) 565-1101
(732) 565-3776 FAX
Disclaimer- Copyright 2005 - All Rights Reserved